I20M (p.Ile20Met) variant of KRT16 (Keratin, type I cytoskeletal 16)

I20M (p.Ile20Met) in KRT16 (Keratin, type I cytoskeletal 16) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.05 / 1. The record also includes population frequency data and structural context.

I20M (p.Ile20Met) variant details